Atlas Trials

Malignant Ovarian Mixed Epithelial Tumor

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Malignant Ovarian Mixed Epithelial Tumor

RecordFirmDate
TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer (NCT01294293)Gynecologic Oncology Group2011-03-01
Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00814086)Gynecologic Oncology Group2009-02-01
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy (NCT00899093)Gynecologic Oncology Group2007-09-01
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00262847)National Cancer Institute (NCI)2005-09-01
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00060359)Gynecologic Oncology Group2003-04-01
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer (NCT00004221)Gynecologic Oncology Group1999-11-01

Track Malignant Ovarian Mixed Epithelial Tumor automatically

Every clearance here is in the API, with alerts when new ones post.